Blue Trust Inc’s Regencell Bioscience RGC Stock Holding History

Blue Trust Inc’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31K	Hold	216	–	–	﹤0.01%	2255
2026 Q1	$5.49K	Hold	216	–	–	﹤0.01%	1969
2025 Q4	$4.54K	Buy	+216	New	+$3.51K	﹤0.01%	2009

Other funds holding RGC

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Blue Trust Inc's RGC Position: Q2 2026 in Review

Blue Trust Inc held its Regencell Bioscience (RGC) position steady in Q2 2026 at 216 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Blue Trust Inc first reported a position in RGC in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.49K in Q1 2026. 2 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

Blue Trust Inc held 216 shares of Regencell Bioscience worth $1.31K as of Q2 2026.
Blue Trust Inc left its Regencell Bioscience share count unchanged in Q2 2026.
Regencell Bioscience made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2255 holding.
Blue Trust Inc first reported a position in Regencell Bioscience in Q4 2025 and has held it in 3 quarters since.
Blue Trust Inc's Regencell Bioscience position peaked at $5.49K in Q1 2026.
2 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.